T lymphocytes: A role in hypertension?

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 2, 2010, Pages 181-186

  Schiffrin, Ernesto L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Blood pressure; Inflammation; Interleukin; Target organ damage; Th1; Th17; Th2; Treg; Vascular remodeling

Indexed keywords

ANGIOTENSIN II; DEOXYCORTICOSTERONE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3;

CARDIOVASCULAR DISEASE; HUMAN; HYPERTENSION; INFLAMMATION; INTERFERON PRODUCTION; KIDNEY DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; METABOLIC DISEASES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 76749083825     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283360a2e     Document Type: Review

References (38)

1. Eriksson EE, XieX, Werr J, et al. Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med 2001; 194:205-218.
2. Virdis A, Schiffrin EL. Vascular inflammation: a role in vascular disease in hypertension? Curr Opin Nephrol Hypertens 2003; 12:181-187.
3. Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci 2007; 112:375-384.
4. Verlohren S, Muller DN, Luft FC, Dechend R. Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension 2009; 54:439-443.
5. De Ciuceis C, Amiri F, Brassard P, et al. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol 2005; 25:2106-2113.
6. Ko EA, Amiri F, Pandey NR, et al. Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-csf deficient mice. Am J Physiol (Heart Circul Physiol) 2007; 292:H1789-H1795.
7. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361:888-898.
8. Hall BM, Jelbart ME, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med 1985; 162:1683-1694.
9. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287-296.
10. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and nonself. Nat Immunol 2005; 6:345-352.
11. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8:523-532.
12. Samanta A, Li B, Song X, et al. TGF-betaand IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc Natl Acad Sci USA 2008; 105:14023-14027.
13. ChatilaTA, Blaeser F, HoN, et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic dysregulation syndrome. J Clin Invest 2000; 106:75-81.
14. Khattri R, Cox T, Yasayko S-A, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4:337-342.
15. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330-336.
16. Borsellino G, Kleinewietfeld M, Di Mitri D, et al. Expression of ectonucleo-tidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110:1225-1232.
17. Buckner JH, Ziegler SF. Regulating the immune system: the induction of regulatory T cells in the periphery. Arthritis Res Ther 2004; 6:215-222.
18. Watanabe K, Rao VP, Poutahidis T, et al. CTLA-4 blockade abrogates protection by regulatory T cells in a mouse model of microbially-induced innate immune-driven colitis. Infect Immun 2008; 76:5834-5842.
19. Kobie JJ, Shah PR, Yang L, et al. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine. J Immunol 2006; 177:6780-6786.
20. Shao J, Nangaku M, MiyataT, et al. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003; 42:31-38.
21. Guzik TJ, Hoch NE, Brown KA, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204:2449-2460.
22. Gratze P, Dechend R, Stocker C, et al. Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension. Circulation 2008; 117:2645-2656.
23. Madhur M, Guzik T, McCann L, Harrison D. Interleukin 17 is critical to angiotensin II-induced hypertension and vascular dysfunction in vivo. Abstract 030, 63rd High Blood Pressure Research Conference 2009, American Heart Association, p. 69.
24. Lob HE, Marvar PJ, Guzik TJ, et al. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension 2009 (in press), doi 10.1161/hypertensiona-ha.109.1 42646.
25. Crowley SD, Frey CW, Gould SK, et al. Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am J Physiol Renal Physiol 2008; 295:F515-F524.
26. Zorzanelli Rocha V, Folco EJ, Sukhova G, et al. Interferon-7, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 2008; 103:467-476.
27. Ait-Oufella H, Salomon BL, Potteaux S, et al. Natural regulatory cells control the development of atherosclerosis in mice. Nature Med 2006; 12:178-180. (Pubitemid 43214743)
28. Taleb S, Tedgui A, Mallat Z. Regulatory T-cell immunity and its relevance to atherosclerosis. J Intern Med 2008; 263:489-499.
29. Viel EC, Lemarie CA, Benkirane K, Schiffrin EL. Chromosome 2 upregulates inflammation and downregulates CD8+CD25+ cells in vascular wall of hypertensive rats. Hypertension 2008; 52:e34.
30. Cowley AW Jr, Liang M, Roman RJ, et al. Consomic rat model systems for physiological genomics. Acta Physiol Scand 2004; 181:585-592.
31. Galkina E, Harry BL, Ludwig A, et al. CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall. Circulation 2007; 116:1801-1811.
32. Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T cell responses: potential role in the control of atherosclerosis. Curr Opin Lipidol 2005; 16:518-524.
33. Rodriguez-Iturbe B, Pons H, Quiroz Y, et al. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 2001; 59:2222-2232. (Pubitemid 32467615)
34. Valaperti A, Marty RR, Kania G, et al. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 2008; 180:2686-2695.
35. Kvakan H, Kleinewietfeld M, Qadri F, et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 2009; 119:2904-2912.
36. Kinsey GR, Sharma R, Huang L, et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 2009; 20:1744-1753.
37. Hamet P, Pausova Z, Adarichev V, et al. Hypertension: genes and environment. J Hypertens 1998; 16:397-418.
38. Lipoldova M, Havelkova H, Badalova J, Demant P. Novel loci controlling lymphocyte proliferative response to cytokines and their clustering with loci controlling autoimmune reactions, macrophage function and lung tumor susceptibility. Int J Cancer 2005; 114:394-399.